OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up

OncoGenex Doubles Down on Prostate Cancer, As Competition Heats Up
OncoGenex and Teva began collaborating back in December 2009 on the plan to co-develop custirsen as a new treatment for advanced prostate cancer. The OncoGenex drug is designed to work differently than the others, as it is genetically engineered to …
Read more on Xconomy

New North American Study Shows Prostate Cancer Treatment Results Using High
The largest clinical study in North America using High Intensity Focused Ultrasound to treat prostate cancer has just been published by the online British Journal of Urology (International). The data shows results of over 400 patients tested over 4 …
Read more on PR Web (press release)

This entry was posted in Cancer Prostate Treatment and tagged , , , , , , . Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>